Healix Announces Strategic Partnership with WeInfuse


SUGAR LAND, TX (December 6, 2018) – Healix, the nation’s leader in providing physician office-based infusion services, announces a strategic partnership with WeInfuse, the first and only end-to-end workflow software application purpose-built for infusion centers. Healix has made a significant investment in WeInfuse, and in turn, WeInfuse will be developing a highly-customized enterprise level software platform to bolster Healix’s existing IT systems.

Media Contacts

Kelly Anderson, Vice President of Marketing, Healix, LLC, (281) 295-4110, [email protected]

View All

Phase II and Phase III Studies

Healix regularly and actively supports Phase II and Phase III clinical trials in each of our specialty areas, including active studies in therapies for COVID-19, Multiple Sclerosis and Intestinal Bowel Disease.

For information on partnering with Healix on a study, please contact us.